Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
, 92 (3), 524-6

Thiamine-responsive Megaloblastic Anemia Syndrome

Case Reports

Thiamine-responsive Megaloblastic Anemia Syndrome

Ali Bay et al. Int J Hematol.


Thiamine-responsive megaloblastic anemia (TRMA) syndrome usually associated with diabetes mellitus, anemia and deafness, due to mutations in SLC19A2, encoding a thiamine transporter protein. The onset of disease is usually seen during infancy or at early childhood and most of the TRMA patients are originated from consanguineous families. In this case, we report a 5-month-old boy who had diagnosis of TRMA during evaluations for his anemia and thrombocytopenia. The diagnosis of TRMA should be kept in mind in differential diagnosis of megaloblastic anemia especially in the populations where the consanguinity is frequent.

Similar articles

See all similar articles

Cited by 2 articles


    1. Pediatr Diabetes. 2002 Dec;3(4):205-9 - PubMed
    1. Eur J Endocrinol. 2006 Dec;155(6):787-92 - PubMed
    1. Nat Genet. 1999 Jul;22(3):309-12 - PubMed
    1. Acta Paediatr. 2006 Jan;95(1):99-104 - PubMed
    1. Turk J Pediatr. 2009 May-Jun;51(3):301-4 - PubMed

Publication types

MeSH terms


Supplementary concepts

LinkOut - more resources